Princess Adila: Her Royal Highness, Her Human Mission
Inside the remarkable journey of Princess Adila bint Abdullah Al Saud. An exclusive interview for CancerWorld. When I entered the room, it felt as though I had stepped into a page from an Arabian fairytale. The room was quiet and…
Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs.…
It’s no longer taboo to suggest that some metastatic breast cancers may be curable
It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the…
NEWS
CancerWorld #105 (July 2025)
At CancerWorld, we believe the future of oncology is shaped not only by what we discover but by how we care, who we listen to, and what we choose to build. On our dual cover, we feature Suheir Rasul. As…
CONTENTS
ARTICLES
Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
It was 2018, and I was a fifth-year medical student at Yerevan State Medical University. Word spread that our new oncology professor was someone extraordinary: Gevorg Tamamyan - a Harvard-trained, Nature-published pioneer of pediatric oncology in Armenia and president of…
